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ARTICLE
Ubiquitin transfer by a RING E3 ligase occurs
from a closed E2~ubiquitin conformation
Emma Branigan 1, J. Carlos Penedo 2,3✉ & Ronald T. Hay 1✉
Based on extensive structural analysis it was proposed that RING E3 ligases prime the
E2~ubiquitin conjugate (E2~Ub) for catalysis by locking it into a closed conformation, where
ubiquitin is folded back onto the E2 exposing the restrained thioester bond to attack by
substrate nucleophile. However the proposal that the RING dependent closed conformation
of E2~Ub represents the active form that mediates ubiquitin transfer has yet to be experi-
mentally tested. To test this hypothesis we use single molecule Förster Resonance Energy
Transfer (smFRET) to measure the conformation of a FRET labelled E2~Ub conjugate, which
distinguishes between closed and alternative conformations. We describe a real-time FRET
assay with a thioester linked E2~Ub conjugate to monitor single ubiquitination events and
demonstrate that ubiquitin is transferred to substrate from the closed conformation. These
findings are likely to be relevant to all RING E3 catalysed reactions ligating ubiquitin and other
ubiquitin-like proteins (Ubls) to substrates.
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Ubiquitination is a eukaryotic post-translational modifica-tion that modulates a host of cellular processes1. Mod-ification is mediated by an E1 activating enzyme (E1), an
E2 conjugating enzyme (E2) and an E3 ligase (E3). The E1 cat-
alyses formation of a highly reactive thioester linked conjugate
(E2~Ub) between ubiquitin and E22. The largest class of ubiquitin
E3 ligases, which is represented by RING E3s, bind both substrate
and E2~Ub and facilitate transfer of ubiquitin from the E2 to
substrate. Crystal structures of stable E2~Ub conjugates in
complex with RING E3 ligases have revealed that the E2~Ub
conjugate binds to RING E3 ligases in a closed conformation3–6,
with some requiring RING domain dimerisation7,8, while others
require a non-RING element such as phosphorylation or an
additional ubiquitin9,10, to stabilise the closed conformation. The
closed conformation has also been observed for other RING E3
catalysed reactions involving Ubls such as SUMO and Nedd811,12.
Ubiquitin in an E2~Ub conjugate can exist in multiple con-
formations and NMR experiments have generated open and
closed models of the E2~Ub conjugate alone13–15 and in complex
with a RING/Ubox in solution16.
Despite the wealth of structural and biochemical data sup-
porting the closed conformation as the active conformation in
RING E3 catalysis, it has not been observed directly in a ubi-
quitination reaction as the conformation from which the E2~Ub
conjugate reacts. We therefore decided to use single-molecule
FRET to access conformational states of the E2~Ub conjugate
undergoing a RING E3 catalysed ubiquitination reaction in real-
time. Using Ubc13 as an E2, we design a FRET labelled
Ubc13~Ub conjugate and define the high FRET state as the closed
conformation using a stable isopeptide linked E2~Ub conjugate,
while the low FRET state represents more open conformations.
Using RNF4 as a RING E3 ligase, which targets SUMOylated
proteins for ubiquitination, and a reactive thioester linked E2~Ub
conjugate, our real-time smFRET experiment reveals that the
RNF4 catalysed ubiquitination reaction of a SUMOylated sub-
strate proceeds from the high FRET state or closed conformation
of the E2~Ub conjugate.
Results
RNF4/Ubc13~Ub assembly and ubiquitin transfer requires
UEV. We have previously crystallised Ubc13~Ub in complex with
the RNF4 RING domain dimer and the Ubc13 binding partner,
UEV, where the Ubc13~Ub conjugate adopts the closed or active
conformation with ubiquitin folded back onto the E2, exposing
the thioester to nucleophilic attack by K63 of the substrate ubi-
quitin (Fig. 1a). Crystallisation of the complex without UEV also
yielded the same closed conformation of the Ubc13~Ub con-
jugate5 (Fig. 1b), even although RNF4 fails to transfer ubiquitin
from the Ubc13~Ub conjugate in the absence of UEV (Fig. 1c, d).
In the assay, formation of K63–linked ubiquitin chains on the
substrate results in an increasing fluorescence polarisation signal,
while a low fluorescence polarisation signal is observed in assays
lacking UEV (Fig. 1c). In the absence of UEV ubiquitin cannot be
transferred to substrate leading to a build up of the thioester
linked Ubc13~Ub conjugate as shown by analysis of the reaction
products in SDS-PAGE (Fig. 1d, Supplementary Fig. 1). We
found that the RNF4 RING domain dimer has a higher binding
affinity for the Ubc13~Ub conjugate when in complex with UEV
(Fig. 1e) suggesting that UEV plays a central role in priming of
the Ubc13~Ub conjugate for catalysis when bound to the dimeric
RING of RNF4. Crystal structures in the presence and absence of
UEV show complex formation between the RNF4 RING domain
dimer and the Ubc13~Ub conjugate in the closed conformation,
which is believed to represent the active conformation of the
E2~Ub conjugate. However, the high concentration of protein
used for crystallisation of the complex, may allow the Ubc13~Ub
conjugate to adopt the closed conformation, even although it is
incapable of ubiquitin transfer. We therefore decided to use
smFRET to interrogate the structure of the Ubc13~Ub conjugate
alone and in response to RNF4 and UEV binding, and RING E3
catalysed ubiquitin transfer.
UEV and RNF4 stabilise the closed conformation of
Ubc13~Ub. Single molecule fluorescence approaches have been
applied to the ubiquitin system17–19; but not to follow RING
catalysed transfer of ubiquitin from E2 to substrate. We thus
designed a Ubc13~Ub conjugate labelled with the Cy3B-
AlexaFluor 647 FRET pair (R0= 60 Å) where proximity of the
FRET labels in the closed conformation yields a high FRET
efficiency, while the large distance between the labels in the more
open conformation results in a low FRET efficiency (Fig. 2a,
Supplementary Fig. 2a, b). The closed and open conformations
represent the shortest and longest distance between the FRET
labels respectively, however, occupation of ubiquitin in the space
between a closed and open conformation of ubiquitin with
respect to the E2, may produce an intermediate FRET efficiency.
We used a stable isopeptide linked Ubc13~Ub conjugate3,5 to first
determine the FRET state of the conjugate in solution and the
influence that UEV and the RNF4 RING domain dimer have on
its conformation. The dye-labelled conjugate containing his-
tagged ubiquitin bound with similar efficiency to the RNF4 RING
domain dimer as the untagged and unlabelled conjugate (Fig. 1e,
Supplementary Fig. 2c).
The Ubc13~Ub conjugate alone accesses a wide range of FRET
states at low temperature (12 °C) and exhibits a slight preference
(41%) for a high FRET state with a FRET efficiency value (EFRET)
of 0.71, indicating that the closed conformation is favoured
(Supplementary Figs. 3 and 4a). At higher temperatures (22 and
35 °C), an intermediate FRET state (EFRET ~0.57) and a low FRET
state (EFRET ~ 0.36) are favoured and no high FRET state was
observed (Fig. 2b, Supplementary Fig. 4b, c). At all temperatures,
in the presence of UEV, the low FRET population is stabilised
while the intermediate and high FRET states are destabilised,
indicating a more open conformation of the conjugate in complex
with UEV (Fig. 2b, Supplementary Figs. 3 and 4a–c). At all
temperatures, addition of the RNF4 RING domain dimer to the
Ubc13~Ub conjugate in complex with UEV, captures the high
FRET state, consistent with stabilisation of a closed or active
conformation of the Ubc13~Ub conjugate (Fig. 2b, Supplemen-
tary Figs. 3 and 4a–c). In the absence of UEV, the RNF4 RING
domain dimer does not stabilise the high FRET state at 22 °C
(Fig. 2b, Supplementary Fig. 4b), showing that a preassembled
UEV/Ubc13~Ub complex is required for the RING dimer to
capture the closed conformation. Most single-molecule trajec-
tories displayed the same FRET state until photobleaching
occurred and only 1% of them showed rare interconversion
events between FRET states within the time window of the
measurement (~1min) (Fig. 2c, Supplementary Fig. 5a–c). Cross-
correlation analysis of the predominant single-state trajectories
confirmed the absence of fast hidden dynamics within our time
resolution of 100 ms for each of the three FRET states observed
(Supplementary Fig. 6a–c). Taken together, these data highlight
the long-lived stability of each of the complexes present in
solution at equilibrium conditions. To establish that changes in
FRET observed in the Ubc13~Ub conjugate after addition of UEV
and RNF4, were a consequence of UEV and RNF4 binding, we
analysed a series of mutations that disrupt UEV-E2 and RNF4-
E2~Ub interactions and reduce ubiquitination activity (Supple-
mentary Fig. 7a–d). Single-molecule FRET histograms at 22 °C of
the Ubc13~Ub conjugate alone (Fig. 2b), or in the presence of
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these mutant proteins (Supplementary Fig. 7e), were indistin-
guishable indicating that changes in smFRET upon addition of
wild-type UEV and the RNF4 RING domain dimer were due to
direct binding to the Ubc13~Ub conjugate.
Multiple conformations of ubiquitin with respect to Ubc13
may contribute to the intermediate FRET state. As the
intermediate FRET state is detected in the presence of UEV
(Fig. 2b, Supplementary Figs. 3 and 4a–c), this indicates that the
space occupied by UEV can be excluded as a region that
isopeptide linked ubiquitin can occupy in the intermediate FRET
state (Fig. 1a). Increased temperature is anticipated to destabilise
the high FRET state or closed conformation due to breakage of
the hydrogen-bonding network in the active site groove that is
required for adopting the closed conformation and drives
specificity for catalysis in the active site3. As a result the C-
terminal tail of ubiquitin will sit outside the active site groove
similar to a previous NMR model13 leading to a sub-optimal
conformation. This conformation may give rise to the inter-
mediate FRET state (Fig. 2b, Supplementary Figs. 3 and 4a–c), in
particular in the presence of UEV and it is likely that the
hydrophobic interaction between ubiquitin and Ubc13 in the
E2~Ub conjugate, is still engaged in this conformation.
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Fig. 1 RNF4/Ubc13~Ub assembly and ubiquitin transfer requires UEV. a Structural model of the RNF4 RING domain dimer (cyan) in complex with the
Ubc13~Ub conjugate (Ubc13 in grey, Ub in yellow), UEV (raspberry) and acceptor ubiquitin (green) (PDB 5AIT). b Crystal structure of the RNF4 RING
domain dimer in complex with the Ubc13~Ub conjugate alone (PDB 5AIU). For a, b, binding of only one Ubc13~Ub conjugate is displayed for clarity. c
Fluorescence polarisation ubiquitination assay showing the effect of UEV on K63-linked polyubiquitin chain formation using fluorescein labelled version of
Ubiquitin, Ub (5-IAF). Data points represent the mean of n= 3 independent experiments and error bars represent ±s.d. Data points are represented for the
Reaction by green circles, for the Reaction - ATP by black triangles and for the Reaction - UEV by blue squares, with a line drawn in the same colour
through each data point in a reaction. Error bars are omitted when the error is smaller than the data point. d SDS-PAGE analysis of fluorescence
polarisation ubiquitination assays shown in c, under non-reducing (above) and reducing (below) conditions imaged using fluorescein filter. e RNF4 RING
domain dimer pull-down experiment showing the effect of UEV on Ubc13~Ub conjugate binding, analysed by western blot. WT denotes a wild-type RING
domain, while Mut denotes a RING domain containing E2~Ub binding site mutations (M140A and R181A). Linearly fused RING domain dimers are used to
ensure the RING domain dimers of RNF4 are constitutively dimeric. For d, e, the same colour scheme is used as in c. Source data are provided as a Source
Data file.
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Fig. 2 UEV and RNF4 stabilise the closed conformation of Ubc13~Ub. a Modelled accessible volume of FRET dyes (Cy3 in green and AlexaFluor 647 in
red) and average distance measurement for E2~Ub conjugate closed and open conformations. b smFRET histograms (cyan) showing the isopeptide linked
E2~Ub conjugate conformation alone and in complex with UEV and the RNF4 RING domain dimer at 22 °C. The E2~Ub conjugate conformation in the
presence of the RNF4 RING domain dimer is also shown. Gaussians are fitted to the low FRET state (green), the intermediate FRET state (red) and the high
FRET state (blue). The multiple Gaussian fit is shown in black. The pie charts to the right of each histogram show the percentage contribution of each FRET
state to the overall population, using the same colour scheme as the Gaussians fitted to the smFRET histograms. c Representative single-molecule traces
for the E2~Ub conjugate in complex with UEV and the RNF4 RING domain dimer. Each panel shows the Cy3B donor intensity (green), the AlexaFluor 647
acceptor intensity (red) and the FRET trace (black). Traces demonstrating the stability of the low, intermediate and high FRET states observed for most
complexes are shown in the upper panels. Examples of traces within the 1% that show interconversion between FRET states are shown in the lower panels.
Source data are provided as a Source Data file.
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The role of specific amino acids in the E2~Ub conformation.
To directly test the contribution of hydrophobic contacts in each
of the complexes present in solution and confirm that the high
FRET state represents the closed conformation we made muta-
tions in the hydrophobic interaction surface and analysed them
using smFRET. We used the I44A mutation in ubiquitin (Fig. 3a),
which has dramatically reduced ubiquitination activity in vitro
(Fig. 3b, Supplementary Fig. 8a, b) and disrupts the closed con-
formation by reducing the interaction between the hydrophobic
patch of ubiquitin and E2. This mutation stabilises the low FRET
state indicating a more open conformation and the conjugate
cannot access the high FRET state or closed conformation, even
in the presence of UEV and the RNF4 RING domain dimer
(Fig. 3c, Supplementary Fig. 9a). An L106A mutation in Ubc13
that is part of the same hydrophobic interface as Ub I44A, dis-
plays similar ubiquitination defects in vitro (Fig. 3a, b, Supple-
mentary Fig. 8a, b), and has a similar, but less pronounced, effect
on the conformation of the Ubc13~Ub conjugate (Fig. 3d, Sup-
plementary Fig. 9b). In addition to destabilising the high FRET
state, these mutations also destabilise the intermediate FRET state
(Fig. 3d, Supplementary Fig. 9b), indicating that the hydrophobic
interaction maintains both the intermediate and high FRET
states, and when disrupted a more open conformation or low
FRET state is favoured. An S32A mutation in UEV20 that per-
turbs binding of the acceptor ubiquitin (Fig. 3a), was defective in
RNF4 dependent substrate ubiquitination (Fig. 3b, Supplemen-
tary Fig. 8a, b), but retained the ability to activate the Ubc13~Ub
conjugate in an RNF4 dependent lysine discharge assay5. To
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Fig. 3 The role of specific amino acids in the E2~Ub conformation. a Locations of mutations made within the complex (PDB accession number 5AIT).
b Fluorescence polarisation ubiquitination assay showing the effect of mutations on K63-linked polyubiquitin chain formation. Data points represent the
mean of n= 3 independent experiments and error bars represent ±s.d. Data points are represented for the reaction containing Ub I44A by yellow triangles,
Ubc13 L106A by grey inverted triangles and UEV S32A by raspberry diamonds, with a line drawn in the same colour connecting each data point in a
reaction. Error bars are omitted when the error is smaller than the data point. c smFRET histograms (yellow) showing the E2~Ub conjugate conformation
containing Ub I44A alone and in complex with UEV and the RNF4 RING domain dimer. d smFRET histograms showing the conformation of the WT E2~Ub
conjugate (cyan) and the E2~Ub conjugate containing either Ub I44A (yellow) or Ubc13 L106A (purple) at 22 °C. For c, d, pie charts to the right of each
histogram highlight the percentage contribution of each FRET state to the overall population. e Normalised smFRET histograms (magenta) showing
conformation of the E2~Ub conjugate in complex with the RNF4 RING domain dimer and either WT UEV (left panel) or UEV S32A (right panel) at 22 °C.
The multiple Gaussian fit is represented by a black dotted line. Pie chart insets show the percentage contribution of each FRET state to the overall
population. Source data are provided as a Source Data file.
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determine if the S32A mutation in UEV could co-operate with
RNF4 to restrain the Ubc13~Ub conjugate in the closed con-
formation, we carried out smFRET analysis of the wild type and
S32A versions of UEV. This revealed that the conformation of the
Ubc13~Ub conjugates were indistinguishable and indicated that
stabilisation of the closed conformation was independent of
acceptor ubiquitin binding to UEV (Fig. 3e). These data also
indicate that none of the FRET states observed are a consequence
of ubiquitin binding to UEV.
Single ubiquitination events revealed by real-time smFRET.
Use of stable isopeptide linked Ubc13~Ub conjugate allowed us
to identify the high FRET state as the closed conformation and
indicated that both UEV and RNF4 were required to restrain the
Ubc13~Ub conjugate in this conformation. To directly test the
hypothesis that the closed conformation is the active form of the
Ubc13~Ub conjugate requires a method that reveals the FRET
state(s) from which ubiquitin transfer to substrate occurs. This
necessitated attaching the same FRET dyes at identical positions
used for the isopeptide linked conjugate to an reactive thioester
linked conjugate (Supplementary Fig. 10a, b). The labelled con-
jugate modified the substrate in a biochemical assay with similar
efficiency to the WT conjugate (Supplementary Fig. 11). smFRET
analysis at 22 °C of the reactive thioester linked E2~Ub conjugate
alone revealed that while the thioester has access to all three
previously defined FRET states, the high FRET state or closed
conformation is more populated in comparison to the stable
isopeptide linked E2~Ub conjugate (Supplementary Fig. 12a, b).
This may be a consequence of differences in the length and
precise geometry of the linkage between ubiquitin and Ubc13 in
the isopeptide mimic and the native thioester bonds. In the
smFRET experiment we immobilised the unstable thioester linked
Ubc13~Ub conjugate onto the surface for imaging and injected
the reaction components for ubiquitination including UEV,
RNF4 and Ub~4xSUMO-2 substrate. We monitored, in real-time,
transfer of Cy3B-labelled ubiquitin from the E2~Ub conjugate
onto substrate, which diffuses into solution. This reaction results
in simultaneous loss of both donor and acceptor signals as well as
complete loss of the FRET signal (Fig. 4a). This is evident from
the decrease in number of FRET pairs before and after the
reaction has occurred (Fig. 4b). Following the cumulative inten-
sity of fluorescent spots over time produces a stable fluorescent
signal with the injection of UEV alone, while the injection of all
reaction components including UEV, RNF4 and substrate, results
in the loss of fluorescence as a result of RNF4 catalysed ubiquitin
transfer to substrate (Fig. 4c). A similar trend is observed for the
Cy3B donor signal, while the AlexaFluor 647 acceptor signal
experiences a slightly faster loss of signal in the UEV injection in
comparison to Cy3B due to background photobleaching events
for AlexaFluor 647. Single-molecule trajectories demonstrate
stable Cy3B and AlexaFluor 647 intensities lasting hundreds of
seconds following a UEV only injection as well as the loss of
AlexaFluor 647 due to slow photobleaching events and con-
comitant Cy3B recovery (Fig. 4d). The ubiquitination reaction is
characterised by the rapid simultaneous loss of Cy3B and Alex-
aFluor 647 as well as the resultant FRET (Fig. 4d), as set out in the
experimental design (Fig. 4a). There is no recovery of FRET
within the single molecules that have undergone ubiquitin
transfer. Combined analysis of single molecule traces shows a
significant portion of E2~Ub conjugates react upon injection of
reaction components (~60%), compared to injection of UEV only
(~14%) (Fig. 4e). A small portion of the sample contains only
Cy3B due to under-labelling with AlexaFluor 647 or prior pho-
tobleaching of AlexaFuor 647, however, a reaction was also
observed in these conjugates (Fig. 4e).
RNF4 catalyses ubiquitin transfer from a closed conformation.
Contour-plots of FRET trajectories in a 90-s time-window fol-
lowing initiation of the ubiquitination reaction showed the rate of
FRET loss due to ubiquitin transfer to substrate depends on RNF4
concentration and FRET loss was not observed in the absence of
RNF4 or with an RNF4 mutant unable to bind the Ubc13~Ub
conjugate (Fig. 5a). Incubation in the presence of UEV and RNF4
but in the absence of substrate also resulted in no loss of FRET in
the contour plot and cumulative intensity of fluorescent spots
over time produced a stable fluorescent signal (Supplementary
Fig. 13a, b), indicating that ubiquitin is specifically transferred to
substrate and is not discharged to any other components of the
reaction mixture. Single-molecule dwell-time analysis demon-
strated that ubiquitin transfer rates can be distinguished from
slow Cy3B and AlexaFluor 647 photobleaching events and
quantified via dwell time of the FRET signal (Fig. 5b, c, Supple-
mentary Fig. 13c). Ubiquitin transfer reactions from both Cy3B
only and FRET containing conjugates show similar rate in ubi-
quitin transfer and dependence on RNF4 (Fig. 5c). The smFRET
population histogram derived from only those molecules under-
going ubiquitin transfer, accurately shows the RNF4 dependent
reaction proceeded from the high FRET state (EFRET~0.71)
similar to that assigned to the closed conformation of the iso-
peptide linked E2~Ub conjugate (Fig. 5d). A low fraction of
molecules reacting at a slower rate and from a low FRET state
were also present in the UEV only injection, indicating that this
was a background reaction that is not dependent on RNF4
(Fig. 5e, f). Contour plots of all FRET active molecules show an
RNF4 dependent loss of FRET from the high FRET state only,
while the middle FRET state is almost constant over time and the
low FRET state is inactive (Supplementary Fig. 14a–c). This is
further demonstrated by histograms generated from 15-s intervals
showing the loss of only the high FRET state population in the
RNF4 catalysed reaction (Supplementary Fig. 14a). In contrast,
the distribution of FRET populations observed for the RNF4
mutant remained unaltered (Supplementary Fig. 14b) even 6 min
after injection, thus confirming the lack of interconversion
between states and the extremely long-lived stability of the dif-
ferent complexes formed (Supplementary Fig. 15a, b). Stabilisa-
tion of the high FRET state in the absence of substrate indicates
RNF4 binding but lack of ubiquitin transfer to substrate (Sup-
plementary Fig. 14c).
Discussion
Previous crystallographic studies of RING E3 ligases bound to
E2~Ub conjugates, show the conjugate restrained in the closed
conformation3,4. Further crystallographic studies of RING bound
E2~Ub conjugates with the addition of substrate, show the
E2~Ub conjugates in the same closed conformation with the
substrate lysine aligned to attack the thioester bond5,11. These
structural studies have employed a range of chemical biology
approaches to stabilise suitable complexes for structural analysis.
Although yielding high-resolution structural information, these
structures represent a snapshot of the arrangement of proteins
prior to the catalytic step. More recent studies have chemically
stabilised substrates in the active site of RING bound E2~Ub
conjugates; in an effort to mimic the transition state of a ubiquitin
transfer reaction12,21. These structures also show stabilisation of
the E2~Ub conjugate in a closed conformation. Stabilisation of
E2~Ub conjugate in complex with RING E3 ligases yields high-
resolution structural gains, however structural information about
the ubiquitination reaction in real time is lost. NMR studies13–16
provided structural information on the conformational states of
the E2~Ub conjugate, however such ensemble measurements
require hours of averaging to generate a model. Mutational and
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biochemical studies have provided insight into the requirement of
the interaction surfaces observed in these complexes in ubiquitin
transfer reactions3–5,11,12,16. However, the structure of the E2~Ub
conjugate has not been directly studied in real-time with a rapid
structural output during a RING E3 catalysed ubiquitin transfer
reaction, to determine the catalytically active conformation.
Similarly, stopped flow biochemical analysis22 generates rapid
kinetics, but it lacks structural information.
In this study, smFRET provided access to the conformation of
individual E2~Ub conjugates in real-time undergoing rapid
substrate ubiquitination. We benefited from the wealth of high-
resolution structural information available, from which we gen-
erated models of open and closed forms of the E2~Ub conjugate.
smFRET analysis of the stable isopeptide linked E2~Ub conjugate
yielded information about the conformational space available in
solution, which includes a variety of closed, open and inter-
mediate conformations. In addition, we directly tested the
hypothesis that the closed conformation represented the active
conformation by monitoring the conformation of the native and
reactive thioester linked E2~Ub conjugate in a real-time RING E3
catalysed ubiquitination reaction. Without any chemical mod-
ifications to the active site we showed that RING E3 catalysed
ubiquitin transfer to substrate occurs from a closed conformation
of the E2~Ub conjugate.
In the real-time ubiquitination reaction we found that RNF4,
UEV and a suitable substrate are required to promote RING E3
catalysed ubiquitin transfer to substrate from a closed con-
formation of the Ubc13~Ub conjugate. In the absence of any of
these three components, ubiquitin transfer did not occur, even
though a closed conformation was accessible to the Ubc13~Ub
conjugate. In essence, while the RING E3 catalysed ubiquitination
reaction occurs from the closed conformation, the closed con-
formation is not the only requirement for ubiquitin transfer. In
addition to RING E3 catalysed ubiquitination, other E2~Ubls
containing SUMO and Nedd811,12 are similarly restrained in the
closed conformation by their cognate RING E3 ligases, indicating
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that the reaction from the closed conformation is likely to be a
universal mechanism for RING E3 catalysis.
Methods
Cloning, expression and purification of recombinant protein. Human Ubc13
(also known as Ube2N) was previously subcloned into the pHISTEV30a vector
using NcoI and HindIII restriction sites5. A sequence encoding an avitag (Gly-Leu-
Asn-Asp-Ile-Phe-Glu-Ala-Gln-Lys-Ile-Glu-Trp-His-Glu) followed by a linker
(Gly-Gly-Ala) was inserted between the TEV cleavage site and Ubc13 using the
NcoI restriction site. A K24C mutation was introduced into Ubc13 using site-
directed mutagenesis. Additional C87K and K92A mutations in Ubc13 were used
to generate the stable isopeptide linked Ubc13~Ub conjugate5. Ubc13 variants were
expressed in E. coli BL21 (DE3) cells and UEV variants with an N-terminal his6
and MPB tag were expressed in E. coli Rosetta 2 (DE3) cells5. Ub~4xSUMO-2 was
expressed with an N-terminal his6 tag in E. coli Rosetta 2 (DE3) ElaD knockout cell
line23. Expression of Ubc13 and UEV variants, and Ub~4xSUMO-2 was induced
with 100 μM IPTG at 20 °C overnight. All cells were pelleted and resuspended in
50 mM Tris pH 7.5, 250 mM NaCl, 10 mM Imidazole and Complete Protease
Inhibitor Cocktail (EDTA free, Roche) and lysed by sonication. Expression of
RNF4 and linear fusions of RNF4 was performed as previously described7. Briefly,
RNF4 constructs containing an N-terminal his6 and MBP tag were expressed in E.
coli Rosetta 2 (DE3) cells with 100 μM IPTG at 20 °C overnight. Pelleted cells were
resuspended in 50 mM Tris pH 7.5, 0.5 M NaCl, 10 mM Imidazole and Complete
Protease Inhibitor Cocktail (EDTA free, Roche) and lysed by sonication. His6
tagged Ubiquitin M-2C was previously cloned into a pHISTEV30a vector encoding
four extra N-terminal residues (Gly-Ala-Cys-Gly) prior to the native ubiquitin N-
terminus3,24. An additional K63R mutation in ubiquitin was used to generate the
reactive thioester linked Ubc13~Ub conjugate. Ubiquitin constructs were expres-
sed in E. coli BL21 (DE3) cells with 1 mM IPTG for 4 h at 37 °C. Pelleted cells were
resuspended in 50 mM Tris pH 7.5, 250 mM NaCl, 10 mM Imidazole and Com-
plete Protease Inhibitor Cocktail (EDTA free, Roche) and lysed by sonication. All
proteins were purified by Ni-NTA chromatography and eluted with 150 mM
imidazole, followed by cleavage with TEV protease and Ni-NTA chromatography
to remove any uncleaved protein, free his6 tag and his6 tagged TEV. All proteins
were purified by size exclusion chromatography on a HiLoad 16/600 Superdex 75
column (GE Healthcare) using 50 mM Tris pH 7.5, 150 mM NaCl and 0.5 mM
TCEP as running buffer. As a result of cloning, Ubc13 has four extra residues (Gly-
Ala-Met-Ser) before the N-terminal avitag after cleavage with TEV protease.
Preparation of biotinylated and dye-labelled protein. Avitagged Ubc13 was
biotinylated in a reaction containing 10 mM Tris pH 7.5, 5 mM MgCl2, 200 mM
KCl, 2.5 mM ATP, 0.5 mM d-biotin, 100 μM avitagged Ubc13 and 16 μM BirA and
incubated at 20 °C for 4 h followed by 4 °C overnight as previously described25.
Reaction products were purified by size exclusion chromatography with a HiLoad
Superdex 75 16/600 column and 50 mM Tris, 150 mM NaCl, and 0.5 mM TCEP,
pH 7.5 as running buffer. Biotinylated Ubc13 K24C C87K K92A was buffer
exchanged into 50 mM Tris, 150 mM NaCl, pH 7.0 using a Centri Pure Zetadex-25
gel filtration column (Generon) and labelled with Cy3B maleimide (GE Healthcare)
at room temperature for 2 h using a five times molar excess of Cy3B. Excess dye
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was removed using a Centri Pure Zetadex-25 gel filtration column and 50 mM Tris,
150 mM NaCl, and 0.5 mM TCEP, pH 7.5 as running buffer. His6 tagged Ubiquitin
M-2C was also labelled using the same protocol but with Cy3B maleimide and
AlexaFluor 647 C2 maleimide (Thermo Fisher Scientific) separately. All buffers
were degassed, all dye labelling reactions and dye-labelled proteins were protected
from light and all products were analysed by intact LC-MS.
Preparation of isopeptide linked Ubc13~Ub conjugate. An isopeptide linkage
between biotinylated and Cy3B-labelled Ubc13 K24C C87K K92A and AlexaFluor
647 labelled his6 tagged Ubiquitin M-2C was generated using a similar method as
described previously3,5. The conjugation reaction containing 50 μM Ubc13, 60 μM
Ubiquitin, 0.8 μM His6-Ube1, 3 mM ATP, 5 mM MgCl2, 50 mM Tris pH 10.0,
150 mM NaCl and 0.5 mM TCEP was incubated at 37 °C for ~21 h. Reaction
products were fractionated by Ni-NTA chromatography to isolate the isopeptide
linked Ubc13~Ub conjugate and unreacted Ubiquitin, which are both his6 tagged.
All buffers were degassed and all dye-labelled proteins were protected from light.
Production and purification of the isopeptide linked Ubc13~Ub conjugate was
analysed by SDS-PAGE and the FRET labelled protein was imaged using Chemi-
Doc MP (Bio-Rad) with Cy3 and AlexaFluor 647 filter settings. Subsequent Coo-
massie blue staining allowed imaging of all proteins using the Coomassie filter
setting. Ubiquitin I44A and Ubc13 L106A containing conjugates were prepared
using the same protocol.
Preparation of thioester linked Ubc13~Ub conjugate. A thioester linkage
between biotinylated Ubc13 K24C and Cy3B-labelled his6 tagged Ubiquitin M-2C
K63R was generated in a reaction containing 50 μM Ubc13, 50 μM Ubiquitin,
0.1 μM His6-Ube1, 3 mM ATP, 5 mM MgCl2, 50 mM Tris pH 7.5, 150 mM NaCl,
0.5 mM TCEP and 0.1% (v/v) NP-40 Alternative that was incubated at 37 °C for
20 min. Reaction products were buffer exchanged into 50 mM Tris, 150 mM NaCl,
pH 7.0 using a Centri Pure Zetadex-25 gel filtration column. The thioester was
labelled on K24C of biotinylated Ubc13 with a five times excess of AlexaFluor 647
C2 maleimide at room temperature for 2 h. Excess dye was removed using a Centri
Pure Zetadex-25 gel filtration column and 50 mM Tris and 150 mM NaCl, pH 7.0
as running buffer. All buffers were degassed and all dye labelling reactions and dye-
labelled proteins were protected from light. Production and labelling of the
thioester linked Ubc13~Ub conjugate was analysed by SDS-PAGE and the FRET
labelled protein was imaged using ChemiDoc MP with Cy3 and AlexaFluor 647
filter settings. Subsequent Coomassie blue staining allowed imaging of all proteins
in the samples using the Coomassie filter setting.
Ubiquitination assays. Fluorescence polarisation ubiquitination assays were per-
formed and analysed as described previously using a fluorescein labelled version of
Ubiquitin M-2C (Ub-5IAF)24. Briefly, 2.5 μM Ubc13, 2.5 μM UEV, 9.6 μM WT
Ubiquitin, 0.4 μM Ub-5IAF, 0.1 μM His6-Ube1, 0.55 μM RNF4, 5.5 μM Ub~4x-
SUMO-2, 5 mM MgCl2, 50 mM Tris pH 7.5, 150 mM NaCl, 0.1% (v/v) NP-40
Alternative, 0.5 mM TCEP were incubated at 20 °C for 20 min taking samples at 0,
2, 5, 10, 15 and 20 min. 3 mM ATP was added after the 0-min time point to start
the reaction. The reaction was stopped at each time point by mixing it with
stopping buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 0.1% (v/v) NP-
40 Alternative, 150 mM EDTA pH 8.0) in a 2:1 ratio. Fluorescence polarisation was
measured using a PHERAstar FS microplate reader with 485 nm excitation and
520 nm emission wavelengths. The assays were resolved by SDS-PAGE under non-
reducing and reducing conditions and Ub-5IAF was imaged using ChemiDoc MP
with the fluorescein filter setting. Subsequent Coomassie blue staining allowed
imaging of all proteins in the assay using the Coomassie filter setting.
The substrate single turnover assay to validate labelled proteins was performed
as previously described7. In all, 15 μM FRET labelled thioester linked Ubc13~Ub
conjugate was mixed in a 1:1 ratio with 15 μM UEV, 1.1 μM RNF4, 11 μM
Ub~4xSUMO-2, 50 mM Tris pH 7.5, 150 mM NaCl, 0.1% (v/v) NP-40 Alternative,
0.5 mM TCEP and the reaction incubated at 20 °C for 10 min and stopped with
non-reducing SDS-PAGE loading buffer. Samples were taken at 0.5, 1, 2, 5 and 10
minutes. A WT Ubc13~Ub thioester linked conjugate, prepared using the same
protocol as described above, was used as a control in this experiment. Ubiquitin in
both Ubc13~Ub conjugates contained a K63R mutation such that only one
ubiquitin was transferred onto the substrate. An RNF4 construct containing full
length RNF4 linearly fused to a second RING domain was used in the ubiquitin
reaction, similar to real-time smFRET experiments. Full-length RNF4 includes four
N-terminal SUMO Interaction Motifs, which engage the Ub~4xSUMO-2 substrate,
and a C-terminal RING domain. One of the E2~Ub binding sites within the RING
domain dimer was mutated (M140A and R181A) allowing only one E2~Ub
conjugate to bind during the ubiquitination reaction. The assay was resolved by
SDS-PAGE and the FRET labelled protein was imaged using ChemiDoc MP with
Cy3 and AlexaFluor 647 filter settings. Subsequent Coomassie blue staining allowed
imaging of all proteins in the assay using the Coomassie filter setting.
Pull-down assay. Binding between an MBP tagged linearly fused dimer of the
RING domain of RNF4 and the Ubc13~Ub conjugate was performed as described
previously7. Production of the linearly fused dimer of the RING domain of RNF4
was described previously3,7 and was used in the pull-down assay to ensure that the
RING domain is constitutively dimeric, which is required for binding of the
Ubc13~Ub conjugate. E2~Ub binding site mutations (M140A and R181A) are used
in a single RING domain or both RING domains to disrupt one or both E2~Ub
binding sites respectively. In the pull-down experiment, Ubc13~Ub conjugates
were mixed at room temperature with His6 MBP tagged RNF4 variants bound to
10 μl amylose beads in 50 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 5% (v/v)
glycerol. The amylose beads were washed by resuspension in 0.5 ml of the same
buffer. The beads were gently pelleted, followed by aspiration of the supernatant. In
the final washing step the beads were resuspended again in 0.5 ml of the same
buffer and placed on 1.4 ml of 50 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM TCEP,
5% (v/v) glycerol and 10% (w/v) sucrose. The beads were quickly and gently
pelleted and the supernatant was aspired. The remaining proteins bound to the
beads were eluted with SDS-PAGE loading buffer and resolved by SDS-PAGE. The
results were analysed by western blotting with anti-ubiquitin primary antibody
(Dilution 1:2000, Z0458, Dako) and anti-rabbit HRP secondary antibody (Dilution
1:10000, A6154, Sigma Aldrich) for the unlabelled Ubc13~Ub conjugate. The FRET
labelled Ubc13~Ub conjugate was analysed by SDS-PAGE and imaged using
ChemiDoc MP with Cy3 and AlexaFluor 647 filter settings. Subsequent Coomassie
blue staining allowed imaging of the proteins using the Coomassie filter setting. All
uncropped gels and blots are provided in the Source Data file.
FRET dye modelling. Cy3 and AlexaFluor 647 were modelled on to the E2~Ub
conjugate using the FRET-restrained positioning and screening (FPS) software26.
As Cy3B maleimide is not available in the FPS software package, the closest
alternative, Cy3 maleimide, was used for modelling purposes. Ubc13 (Chain B) and
Ubiquitin (Chain C) in PDB 5AIT were used for modelling the accessible volume
of FRET dyes as well as the distance between them for the closed conformation of
the E2~Ub conjugate, while the NMR model (PDB accession number 2KJH) was
used for the open conformation of the conjugate. As the cysteine in ubiquitin is
contained within an N-terminal linker that is not present in these PDB files, the
closest surface accessible amino acid, Gln2, was used for attachment and modelling
the dye on ubiquitin. This is likely to result in a distance measurement that is
shorter than expected; therefore, the resulting distance calculations were used as
a guide.
Slide passivation. Slides were passivated as described previously27. Aminosilane
treated slides and coverslips were passivated for 1 to 3 h with a mixture of biotin-
PEG-SVA and PEG-SVA in a mass ratio of 1:100 respectively, dissolved in 100 mM
sodium bicarbonate pH 8.5. Slides and coverslips were rinsed well with methanol
and water and were subsequently assembled into four channels for stable isopep-
tide linked conjugate studies. Single channel slides with tubing and syringe attached
for injection purposes were assembled for real-time reaction studies using the
unstable thioester linked conjugate. Channels were coated with 0.2 mg ml−1 neu-
travidin for 10 min prior to addition of biotinylated FRET labelled proteins.
Single molecule total internal reflection. smFRET experiments were performed
as described previously28. All experiments were performed on a prism-type total-
internal reflection microscope using an inverted microscope (Olympus IX71). A
532-nm laser (Crystalaser) was used for Cy3B excitation and images were collected
on a back illuminated Ixon EMCCD camera (Andor, 512×512 pixels). Cy3B and
AlexaFluor 647 fluorescence were split by dichroic mirrors (DCRLP645, Chroma
Technology) into two channels allowing simultaneous imaging with Cy3B on the
left and AlexaFluor 647 on the right of the EMCCD camera.
Isopeptide linked conjugate smFRET experiments. In total, 50 pM of the stable
isopeptide linked FRET labelled Ubc13~Ub conjugate was bound to a slide pas-
sivated with biotinylated PEG and neutravidin for 10 min. Excess free AlexaFluor
647 labelled ubiquitin was washed from the surface using 50 mM Tris, 150 mM
NaCl, 0.5 mM TCEP, pH 7.5. Imaging buffer containing 50 mM Tris, 150 mM
NaCl, 0.5 mM TCEP, pH 7.5, 1 mM Trolox, 6.25 mM 3,4-protocatechuic acid
(PCA) and 250 nM protocatechuate dioxygenase (PCD) was then added to the
slide. The Ubc13~Ub conjugate was imaged alone and in complex with UEV and
the RING domain dimer of RNF4. One of the E2~Ub binding sites within the
RING domain dimer was mutated (M140A and R181A) allowing only one
Ubc13~Ub conjugate to bind to the RING domain dimer. For complex imaging,
imaging buffer was supplemented with 10 μM UEV and/or 40 μM RING domain
dimer of RNF4. A series of smFRET trajectories were acquired using 100 ms
integration time and within ~30 min of the addition of imaging buffer. Experi-
ments for the WT Ubc13~Ub stable isopeptide linked conjugate were performed at
three different temperatures including 12, 22 and 35 °C, while experiments for
mutant forms of the Ubc13~Ub stable isopeptide linked conjugate and UEV were
performed at 22 °C.
Thioester linked conjugate real-time smFRET experiments. A flow cell was
generated as described previously29. Briefly, tubing was attached to the drilled holes
at each end of the single channel slide. One piece of tubing was placed in an
eppendorf containing the desired solution while a syringe was attached to the other
piece of tubing through which the solution was drawn through the channel by
suction. Using this suction method, 100 pM of the unstable thioester linked FRET
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labelled Ubc13~Ub conjugate was bound to a slide passivated with biotinylated
PEG and neutravidin for 10 min. Excess free Cy3B-labelled ubiquitin was washed
from the surface using 50 mM Tris, 150 mM NaCl, pH 7.0. Free AlexaFluor 647
labelled Ubc13 is not observed due to direct excitation of Cy3B. Prior to the
reaction the slide was washed with 50 mM Tris, 150 mM NaCl, 0.5 mM TCEP, pH
7.5. The UEV injection was performed with 2.5 μM UEV, 50 mM Tris, 150 mM
NaCl, 0.5 mM TCEP, pH 7.5, 0.8% (w/v) d-glucose, 1 mM Trolox, 0.1 mgml−1
glucose oxidase (Sigma) and 0.02 mgml−1 glucose catalase (Sigma). The ubiqui-
tination reaction injection was performed with 2.5 μM UEV, 2.2–4.4 μM RNF4 and
0–5.5 μM Ub~4xSUMO-2, 50 mM Tris, 150 mM NaCl, 0.5 mM TCEP, pH 7.5,
0.8% (w/v) d-glucose, 1 mM Trolox, 0.1 mg ml−1 glucose oxidase (Sigma) and 0.02
mgml−1 glucose catalase (Sigma). An RNF4 construct containing full-length RNF4
linearly fused to a second RING domain was used in the ubiquitin reaction, similar
to the substrate single turnover ubiquitination assay used to validate the proteins.
One of the E2~Ub binding sites within the RING domain dimer was mutated
(M140A and R181A) allowing only one E2~Ub conjugate to bind during the
ubiquitination reaction. Ubiquitin within the Ubc13~Ub conjugate contains a
K63R mutation such that only a single ubiquitin is transferred onto a substrate
molecule, rather than forming ubiquitin chains. smFRET trajectories were acquired
with 1 s integration time at 22 °C.
Data processing. IDL 6.0 was used to process an output containing intensity
versus time for each single-molecule trajectory detected by the EMCCD camera.
Data were analysed in Matlab as described previously30. FRET efficiency (EFRET)
was calculated from the raw Cy3B and AlexaFluor 647 intensity traces using:
EFRET ¼ IA= ID þ αIAð Þ ð1Þ
where ID= donor (Cy3B) intensity, IA= acceptor (AlexaFluor 647) intensity and α=
0.88 accounts for 12% leakage into the AlexaFluor 647 detection channel30. Histo-
grams were prepared by averaging the first ten frames of each single-molecule trace
separately and these averages were combined to produce the overall FRET population.
Histograms were normalised to area unity to compare FRET populations between
samples. Cross-correlation analysis of single-molecule trajectories of donor and
acceptor dyes was carried out using the expression below implemented in matlab:
G τð Þ ¼
P
ID tð Þ  ID
 
IA t þ τð Þ  IA
 
N
P
IDIA
ð2Þ
where ID(t) and IA(t) are the donor and acceptor intensities at a given time point, ID
and IA represent the mean donor and acceptor intensities over the entire single-
molecule trajectory normalised to the total number of data points (N). The G(τ)
function compares the intensity trace of the donor at a time t and the acceptor trace at
a time t+τ.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data underlying all Figures and Supplementary Figures are available in the source data
file and at https://doi.org/10.17630/5f652bc1-1d66-400a-bd76-609b7de0bb25. All other
data are available from the corresponding authors on reasonable request. Source data are
provided with this paper.
Code availability
Code used to generate 3D smFRET histograms in Fig. 2b, Supplementary Figs. 3 and 12a
and contour plots in Fig. 5a, Supplementary Figs. 13a and 14 is included in the source data
file and at https://doi.org/10.17630/5f652bc1-1d66-400a-bd76-609b7de0bb25. Source data
are provided with this paper.
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